- Home
- NMTC vs GDTC Comparison
NMTC vs GDTC Comparison
Compare NMTC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- GDTC
- Stock Information
- Founded
- NMTC 2009
- GDTC 2018
- Country
- NMTC United States
- GDTC Singapore
- Employees
- NMTC N/A
- GDTC N/A
- Industry
- NMTC Medical/Dental Instruments
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- GDTC Health Care
- Exchange
- NMTC Nasdaq
- GDTC Nasdaq
- Market Cap
- NMTC 33.8M
- GDTC 21.5M
- IPO Year
- NMTC N/A
- GDTC 2023
- Fundamental
- Price
- NMTC $0.84
- GDTC $1.94
- Analyst Decision
- NMTC Strong Buy
- GDTC Buy
- Analyst Count
- NMTC 1
- GDTC 1
- Target Price
- NMTC $1.45
- GDTC $5.00
- AVG Volume (30 Days)
- NMTC 221.0K
- GDTC 18.1K
- Earning Date
- NMTC 08-13-2025
- GDTC 01-01-0001
- Dividend Yield
- NMTC N/A
- GDTC N/A
- EPS Growth
- NMTC N/A
- GDTC N/A
- EPS
- NMTC N/A
- GDTC N/A
- Revenue
- NMTC $5,758,777.00
- GDTC $368,838.00
- Revenue This Year
- NMTC $157.28
- GDTC $5.37
- Revenue Next Year
- NMTC $41.79
- GDTC N/A
- P/E Ratio
- NMTC N/A
- GDTC N/A
- Revenue Growth
- NMTC 54.53
- GDTC N/A
- 52 Week Low
- NMTC $0.40
- GDTC $1.20
- 52 Week High
- NMTC $1.39
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- NMTC 55.86
- GDTC 39.79
- Support Level
- NMTC $0.81
- GDTC $1.85
- Resistance Level
- NMTC $1.05
- GDTC $2.26
- Average True Range (ATR)
- NMTC 0.08
- GDTC 0.11
- MACD
- NMTC 0.00
- GDTC -0.02
- Stochastic Oscillator
- NMTC 40.28
- GDTC 31.67
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.